A world of low molecular weight heparins (LMWHs) enoxaparin as a promising moiety—A review
Keywords: انوکساپارین; Heparin; LMWHs; Enoxaparin; Depolymerization; Pre-filled syringe
مقالات ISI انوکساپارین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Enoxaparin and aspirin therapy for recurrent pregnancy loss due to anti-phospholipid syndrome (APS)
Keywords: انوکساپارین; Anticoagulation; Antiphospholipid syndrome; Enoxaparin; Aspirin; Pregnancy; Recurrent miscarriage
Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, for Thromboprophylaxis After Total Hip Arthroplasty in Japan and Taiwan
Keywords: انوکساپارین; edoxaban; factor Xa inhibitor; thromboembolic events; total hip arthroplasty; enoxaparin;
Use of the CRUSADE Bleeding Risk Score in the Prediction of Major Bleeding for Patients with Acute Coronary Syndrome Receiving Enoxaparin in Thailand
Keywords: انوکساپارین; CRUSADE risk score; Enoxaparin; Major bleeding; Acute coronary syndrome; Thailand
Effect of detorsion alone and in combination with enoxaparin therapy on ovarian reserve and serum antimüllerian hormone levels in a rat ovarian torsion model
Keywords: انوکساپارین; Antimüllerian hormone; enoxaparin; ischemia; ovarian follicle; ovary;
In vitro and in vivo evaluation of chitosan graft glyceryl monooleate as peroral delivery carrier of enoxaparin
Keywords: انوکساپارین; Chitosan; Glyceryl monooleate; Oral; Enoxaparin; Polyelectrolyte nanocomplexes;
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: In vitro and in vivo assessment
Keywords: انوکساپارین; ANOVA; analysis of variance; AUC; area under the curve; Alg-CS-NPs; alginate coated chitosan core shell nanoparticles; CS-NPs; chitosan nanoparticles; DSC; differential scanning calorimetry; FTIR; Fourier transform infrared spectroscopy; GI; gastrointesti
Keywords: انوکساپارین; acute coronary syndrome; bleeding; cost; enoxaparin; length of stay
Non-therapeutic anti-Xa levels in medical patients receiving anticoagulant therapy with enoxaparin
Keywords: انوکساپارین; LMWH, Low-molecular-weight-heparinDrug monitoring; Enoxaparin; Factor Xa; Low-molecular-weight heparin
Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient
Keywords: انوکساپارین; Enoxaparin; Venous thromboembolism prophylaxis; VTE prophylaxis; Anti-Xa level; Obese; Trauma
Can Enoxaparin Reduce Thromboembolism Related Events After Primary TKA In Asian Patients?
Keywords: انوکساپارین; total knee arthroplasty; thromboembolism; thromboprophylaxis; enoxaparin
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides
Keywords: انوکساپارین; Heparin; Heparan sulfate; LMW-heparins; Enoxaparin; Dalteparin; Disaccharides
Peak plasma anti-Xa levels after first and third doses of enoxaparin in women receiving weight-based thromboprophylaxis following caesarean section: a prospective cohort study
Keywords: انوکساپارین; Thromboprophylaxis; Caesarean; Enoxaparin; Anti-Xa levels
Exploration of hydrophobic modification degree of chitosan-based nanocomplexes on the oral delivery of enoxaparin
Keywords: انوکساپارین; Chitosan; Glyceryl monostearate; Oral; Enoxaparin; Polyelectrolyte nanocomplexes
Mesenteric ischemia-reperfusion injury: Clearly improved hemodynamics but only minor protection of the rat small intestine by (sub)therapeutic heparin sodium and enoxaparin doses
Keywords: انوکساپارین; Heparin sodium; Enoxaparin; Anticoagulation; Inflammation; Neutrophils; Mesenteric ischemia; Ischemia-reperfusion injury; MicrocirculationHepSo, heparin sodium; Enox, enoxaparin; I/R, ischemia/reperfusion; SMAO, superior mesenteric artery occlusion; UFH,
Bullous Hemorrhagic Dermatosis at Distant Sites: A Report of 2 New Cases Due to Enoxaparin Injection and a Review of the Literature
Keywords: انوکساپارین; Bullous hemorrhagic dermatosis; Enoxaparin; HeparinDermatosis ampollosa hemorrágica; Enoxaparina; Heparinas
Dermatosis ampollosa hemorrágica a distancia; dos nuevos casos por enoxaparina y revisión de la literatura
Keywords: انوکساپارین; Dermatosis ampollosa hemorrágica; Enoxaparina; Heparinas; Bullous hemorrhagic dermatosis; Enoxaparin; Heparin;
Increased use of enoxaparin in pediatric trauma patients
Keywords: انوکساپارین; Enoxaparin; Venous thromboembolism; Pediatric trauma
Incidence of deep vein thrombosis is increased with 30 mg twice daily dosing of enoxaparin compared with 40 mg daily
Keywords: انوکساپارین; Enoxaparin; DVT; Thrombosis; Surgery; 30 BID; 40 QD
Inpatient Enoxaparin and Outpatient Aspirin Chemoprophylaxis Regimen After Primary Hip and Knee Arthroplasty: A Preliminary Study
Keywords: انوکساپارین; thromboprophylaxis; primary joint arthroplasty; aspirin; enoxaparin
Low molecular weight heparin versus unfractionated heparin in patients with acute non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stents
Keywords: انوکساپارین; Enoxaparin; Unfractionated heparin; Acute non-ST-segment elevation myocardial infarction; Drug-eluting stents; Percutaneous coronary intervention
Tromboprofilaxis con enoxaparina para artroplastia total de rodilla: estudio observacional, retrospectivo y multicéntrico comparando el inicio del tratamiento preoperatorio con el postoperatorio
Keywords: انوکساپارین; Heparina de bajo peso molecular; Tromboprofilaxis; Trombosis venosa profunda; Tromboembolismo pulmonar; Artroplastia total de rodilla; Enoxaparina; Low molecular weight heparin; Thromboprophylaxis; Deep venous thrombosis; Pulmonary thromboembolism; Total
Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: Pool-analysis of phase III randomized clinical trials
Keywords: انوکساپارین; venous thromboembolism; prophylaxis; new oral anticoagulants; enoxaparin; major bleeding; orthopedic surgery;
Emerging nonanticoagulant role of low molecular weight heparins on extravillous trophoblast functions and on heparin binding-epidermal growth factor and cystein-rich angiogenic inducer 61 expression
Keywords: انوکساپارین; Extravillous trophoblast invasiveness; low molecular weight heparins; tinzaparin; enoxaparin; HB-EGF; Cyr61; MMP-2; AP-1;
Enoxaparin-Induced Bleeding Resulting in Compartment Syndrome of the Thigh: A Case Report
Keywords: انوکساپارین; enoxaparin; compartment syndrome; spontaneous bleeding
Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome
Keywords: انوکساپارین; Antiphospholipid syndrome; Enoxaparin; Low molecular weight heparin; Recurrent abortion; Unfractionated heparin
Factors influencing enoxaparin anti-Xa activity in surgical critically ill patients
Keywords: انوکساپارین; Enoxaparin; Anti-Xa; Pharmacokinetic; Critical care;
High factor XI, recurrent pregnancy loss, enoxaparin
Keywords: انوکساپارین; Factor XI; thrombophilia; recurrent pregnancy loss; enoxaparin;
Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients
Keywords: انوکساپارین; lung transplantation; venous thromboembolism; anticoagulation; enoxaparin; deep venous thrombosis; pulmonary embolism;
P-selectin/ PSGL-1 Inhibitors versus enoxaparin in the resolution of venous thrombosis: A meta-analysis
Keywords: انوکساپارین; P-selectin; inflammation; venous thrombosis; enoxaparin; animal model; meta-analysis
Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment
Keywords: انوکساپارین; ALL; acute lymphoblastic leukemia; CVL; central venous lines; LMWH; low molecular weight heparin; VTE; venous thromboembolism; AT; anti-thrombin; Acute lymphoblastic leukemia; Venous thromboembolism; Inherited thrombophilia; Enoxaparin;
Liberation of vessel adherent myeloperoxidase by enoxaparin improves endothelial function
Keywords: انوکساپارین; Myeloperoxidase; Enoxaparin; Endothelial function
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from SYNERGY
Keywords: انوکساپارین; Acute coronary syndromes; Bleeding; Chronic kidney disease; Enoxaparin; Heparin; Renal insufficiency;
Bioadhesion and oral absorption of enoxaparin nanocomplexes
Keywords: انوکساپارین; Chitosan; Thiolated chitosan; Trimethyl chitosan; PEGylation; Enoxaparin; Polyelectrolyte complex; Bioadhesion; Oral absorption
Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels
Keywords: انوکساپارین; Alzheimer's disease; Amyloid β; Transgenic mice; Enoxaparin; Treatment
Enoxaparin Anticoagulation Monitoring in the Catheterization Laboratory Using a New Bedside Test
Keywords: انوکساپارین; enoxaparin; bedside test; percutaneous coronary interventionACS, acute coronary syndrome; aPTT, activated partial thromboplastin time; CI, confidence interval; CT, clotting time; IQR, interquartile range; IV, intravenous; LMWH, low molecular weight hepari
Obesity in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial
Keywords: انوکساپارین; Obesity; Acute coronary syndromes; Enoxaparin; Unfractionated heparin; Outcomes
Day 1 care in patients with non-ST-segment elevation myocardial infarction
Keywords: انوکساپارین; Abciximab; Antiplatelet therapy; Bivalirudin; Enoxaparin; Eptifibatide; Glycoprotein IIb/IIIa inhibitors; Non-ST-segment elevation myocardial infarction
Prevention of venous thromboembolism: Improving practice in surgical patients
Keywords: انوکساپارین; VTE; Prophylaxis; Audit; Enoxaparin
Céphalées chez un patient de 21 ans atteint d’une maladie de Goodpasture
Keywords: انوکساپارین; Thrombophlébite cérébrale; Thrombopénie induite par l’héparine; Énoxaparine; Maladie de Goodpasture; Échanges plasmatiquesIntracranial thrombosis; Enoxaparin; Antiglomerular basement membrane disease; Plasma exchange
Hematoma retroperitoneal masivo tras corrección vaginal de prolapso de cúpula
Keywords: انوکساپارین; CirugÃa vaginal; Prolapso de cúpula vaginal; Hematoma retroperitoneal; Enoxaparina; Vaginal surgery; Vaginal vault prolapse; Retroperitoneal haematoma; Enoxaparin;
Gestion du risque thromboembolique veineux en chirurgie carcinologique
Keywords: انوکساپارین; Evénement thromboembolique veineux; Chirurgie carcinologique; Prévention; Daltéparine; Enoxaparine; Venous thromboembolic event; Cancer surgery; Prevention; Dalteparin; Enoxaparin;
Long term administration of LMWH - pharmacodynamic parameters under therapeutic or prophylactic regimen of enoxaparin or tinzaparin in neurological rehabilitation patients
Keywords: انوکساپارین; Enoxaparin; Tinzaparin; TFPI; D-dimer; Anti-FXa-activity; cohort study;
Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: A cross-over study
Keywords: انوکساپارین; Enoxaparin; Hemodialysis; Prothrombin fragment 1 + 2; Thrombin/antithrombin complex; Unfractionated heparin
New oral anticoagulants to revolutionise venous thromboembolism (VTE) management
Keywords: انوکساپارین; Blood clotting cascade; Direct thrombin inhibitors; Deep vein thrombosis; Venous thromboembolism; Oral anticoagulant; Warfarin; Ximelagatran; Dabigatran etexilate; Rivaroxaban; Low molecular weight heparin; Enoxaparin; Direct factor Xa inhibitor
Cost Effectiveness of Enoxaparin in Acute ST-Segment Elevation Myocardial Infarction : The ExTRACT–TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment–Thrombolysis In Myocardial Infarction 25) Study
Keywords: انوکساپارین; enoxaparin; thrombolysis; STEMICI, confidence interval; DRG, diagnosis-related group; ICC, intracluster correlation coefficient; ICER, incremental cost-effectiveness ratio; IQR, interquartile range; LMWH, low-molecular-weight heparin; LYG, life-years gain
Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention : 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial
Keywords: انوکساپارین; percutaneous coronary intervention; enoxaparin; STEEPLE; unfractionated heparinACS, acute coronary syndromes; ACT, activated clotting time; CI, confidence interval; CK, creatine kinase; CK-MB, creatine kinase-myocardial/brain mass; HR, hazard ratio; LMWH,
Effective reversed-phase ion pair high-performance liquid chromatography method for the separation and characterization of intact low-molecular-weight heparins
Keywords: انوکساپارین; Reversed-phase ion pair high-performance liquid chromatography; Low-molecular-weight heparins; Enoxaparin; Dalteparin; Evaporative light scattering detector
Investigation of Freezing- and Thawing-Induced Biological, Chemical, and Physical Changes to Enoxaparin Solution
Keywords: انوکساپارین; AFXa activity; enoxaparin; freezing; thawing; aggregation; low molecular weight heparin;
Investigation of the Effect of Heating on the Chemistry and Antifactor Xa Activity of Enoxaparin
Keywords: انوکساپارین; AFXa activity; enoxaparin; stability; heating; sulfate; fragmentation; aggregation;